October 6, 2017

MNKD Mannkind Corp Losses Due To A Broker?

business man holding his head with text asking questions about stock broker misconduct

S

MannKind Corp. reached a high of about $56 per share in 2014.  From there the stock crashed through all moving averages and showed relative weakness all the way down.  If your broker held this stock and had no exit strategy and failed to limit your losses you may have a valid claim.  Any proper trade plan has risk management and an exit strategy.

Soreide Law Group is representing clients who bought Mannkind Corp., against their financial professionals who recommended MannKind Corp., in large concentrated positions. MNKD may have been unsuitable for some investors and some brokers may have failed to limit losses as the company crashed.  Soreide Law Group has already filed one claim against a National Securities broker for recommending MannKind Corp., to his clients and are interested in speaking with other investors who purchased the stock at any firm with any stock broker.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. Its approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes.

 

MNKD Mannkind Corp Losses
MNKD Mannkind Corp Losses

The company was founded in 1991 and is headquartered in Westlake Village, California. MNKD stock hit a high over $50 in July of 2014 and dropped down to under $5 today. That’s an over 90% drop from high to low. Many stock brokers recommended to their clients to stay the course but that was an ill advised strategy that left many with huge stock losses they will never recover from. If you lost more than $50,000 in MannKind Corporation due to your stock brokers recommendation call 888-760-6552. Soreide Law Group is a securities arbitration firm that handles FINRA arbitrations nationwide against financial professionals. If you bought this stock on your own through a self directed trading platform we cannot assist you but if your broker recommended MNKD please contact us today.
 

Tags

Categories
S H A R E   T H I S   P O S T

Recent Posts

October 23, 2026
Amir Navab Settled Claims At UBS And Great Gable Wealth Management

In June 2024, a customer claim naming Amir Navab (CRD 2437020) settled at Great Gable Wealth Management for $180,000. His BrokerCheck report also shows settled disputes at UBS Financial Services, starting in 2004.

October 23, 2026
A Pending Claim Alleges Brett Ewing Recommended Illiquid Investments

Centaurus Financial appears as the firm on a pending customer arbitration against Brett Ewing (CRD 2904608). The customer filed it on September 14, 2026. According to BrokerCheck, the customer alleges that Ewing recommended unsuitable, illiquid investments from February 2016 through February 2019. Ewing denies the allegations, and no arbitrator has ruled.

October 23, 2026
Eric Kleiner Refused FINRA Requests In A Probe Tied To His Form U5

FINRA found that Eric Kleiner (CRD 4135180) refused to provide documents and information it requested during an investigation. Without admitting or denying the findings, Kleiner consented to the sanction and to the entry of findings.

Contact us Nationwide USA
2401 E. Atlantic Blvd., Suite 305, Pompano Beach, FL 33062
Helping clients recover money across the USA
search
Copyright © 2026 Soreide Law Group, PLLC  |  All Rights Reserved